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A B S T R A C T
Six female patients with encephalitis, mean age 36.5 (17–60) years, were admitted to
the hospital during the 2000–2001 influenza A (H1N1) epidemic in the Osijek – Baranja
County. In three (50.0%) patients, the manifestation of encephalitis occurred on day 4 or
5, and in two (33.3%) patients within 24–48 hours of the onset of influenza symptoms.
The disease manifestations included headache, elevated body temperature, generalized
fatigue, and consciousness disturbance through coma. Three (50.0%) patients had
grand mal seizures. Pathologic electroencephalography findings were recorded in all six
(100%) patients, whereas computed tomography showed cerebral edema in three
(50.0%) patients. Elevated levels of hepatic enzymes and peripheral blood leukopenia
were found in two (33.3%) patients in whom encephalitis developed early upon the onset
of influenza. One (16.6%) of these patients died, whereas permanent sequels remained
in the other two (33.3%) patients.
Key words: cerebral edema, influenza A, epilepsy, coma, encephalitis, encephalo-
pathy.
Introduction
Influenza A epidemics have almost re-
gularly been accompanied by reports of
central nervous system (CNS) impair-
ments associated with influenza A1,2.
CNS impairments usually occur in small
children under the age of 5–6 years, how-
ever, they may also develop in adults.
Encephalitis, encephalopathy and acute
necrotizing encephalopathy have been re-
lated to the influenza virus invasion6,7.
The interest in thorough research into
the CNS effects of influenza A virus has
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been stimulated by recent reports from
Japan on the ever increasing rate of en-
cephalitis or encephalopathy in pediatric
patients during the epidemics of influ-
enza8. The CNS disease generally devel-
oped within 12–48 hours of the onset of
influenza symptoms, and was accompa-
nied by high body temperature, seizures,
coma, and high mortality or permanent
sequels in the survivors8,9. The patients
had elevated levels of serum creatine phos-
phokinase (CPK), tumor necrosis factor
alfa (TNF-) and interleukin (IL-6) in
blood and cerebrospinal fluid (CSF), ab-
normal hepatic enzyme findings, and CSF
pleocytosis9,10.
Brain radiological studies showed le-
sions of the thalamus, brain stem and
cerebellum bilaterally10,11. The influenza
virus (H3) genome was demonstrated in
the CSF of some patients with encephali-
tis or encephalopathy10–12.
The pathophysiology and pathogene-
sis of encephalitis and encephalopathy
associated with influenza A virus has not
yet been fully elucidated, however, this
influenza A complication obviously shows
a rising tendency11,12. Some 150 to 200
cases of encephalitis or encephalopathy
per influenza epidemic are expected in
Japan alone12.
Methods and Results
During the influenza A (H1N1) epi-
demic in the Osijek, Baranja County,
from the end of December 2000 till March
2001, six female patients with encephali-
tis were treated at the University Hospi-
tal »Osijek«. The patients had neither re-
ceived influenza A and B vaccination nor
suffered from any neurological disorder.
The clinical picture and epidemiological
data pointed to influenza, whereas en-
cephalitis of another etiology (Leptospira,
tick-borne meningoencephalitis, cytome-
galovirus, herpes simplex virus 1 and 2,
and enteroviruses) were ruled out in all
six patients. At least fourfold increase in
the influenza A virus antibody titer was
recorded in paired sera of all these pa-
tients.
The patients were aged 17–60, mean
age 36.5 years. In two (33.3%) patients,
the symptoms of encephalitis manifested
within the first 48 hours, and in three
(50.0%) patients on day 4 or 5 of the onset
of influenza. In one (16.6%) patient, en-
cephalitis manifested on day 11 of initial
influenza symptoms. A very severe mani-
festation of encephalitis was recorded in
the patients in whom it developed early
in the course of the underlying disease,
i.e. influenza A. In two patients, the ini-
tial abrupt manifestation of encephalitis
included grand mal seizures and deep
coma. They both had marked leukopenia
(L 1.8  109 and 1.9  109) without gra-
nulocytopenia. One (16.6%) of these two
patients died, whereas two (33.3%) pa-
tients sustained permanent sequels.
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TABLE 1
CLINICAL AND LABORATORY FINDINGS
OF ENCEPHALITIS DURING INFLUENZA A









































EEG = electroencephalogram; CT = computed
tomography; ALT = alanine aminotransferase;
AST = aspartate aminotransferase; CSF = ce-
rebrospinal fluid
Three (50.0%) patients were discharged
from the hospital as fully recovered. All
our patients (100%) had elevated body
temperature (> 40 °C) (Table 1), and had
previously suffered headache and gener-
alized fatigue. Vertigo and cough were
present in five (83.3%), and conscious-
ness disturbances up to deep coma in four
(66.6%) patients. Electroencephalogram
(EEG) was normal in all (100%) patients.
Computed tomography (CT) of the brain
revealed severe cerebral edema and nor-
mal finding in three (50.0%) patients each.
Elevated serum levels of aspartate ami-
notransferase (AST) and alanine amino-
transferase (ALT) were recorded in two
(33.3%), and CSF pleocytosis in four (66.6%)
patients.
Discussion
Influenza viruses are obviously associ-
ated with encephalitis, encephalopathy
and acute necrotizing encephalopathy13.
These severe complications of influenza
mostly occur in small children under the
age of 5–6 years, but are by no means
rare in adults either13,14. These CNS le-
sions have frequently been reported dur-
ing influenza A epidemics caused by
H1N1 and H3N2 virus strains. The neu-
rotropic properties of these viruses, in-
cluding H5N1, have also been demon-
strated experimentally15–17. In all our
patients encephalitis developed during
the influenza A (H1N1) epidemic, as veri-
fied by clinical, epidemiological and sero-
logic studies.
In five patients, the symptoms of en-
cephalitis occurred during the course of
influenza, whereas one patient probably
developed postinfectious encephalitis. In-
terestingly enough, these were middle-
aged women. This might be due to the
higher rate of influenza A and B vaccina-
tion among men, because of more fre-
quent travel and for occupational spe-
cificities.
Two of our patients with the onset of
encephalitis within 24–48 hours of influ-
enza symptoms had elevated serum AST
and ALT levels, and marked peripheral
blood leukopenia. There was no coagula-
tion impairment, which is otherwise seen
in small children with Reye's syndrome
that has also been causally related with
influenza virus. One of these patients
died, whereas the others suffered perma-
nent sequels. Three patients had severe
brain edema, which has been associated
with cytokines (TNF- and IL-6) that
lead to blood-brain barrier permeability,
however, the contribution of local factors
should also be taken in consideration17.
The mechanism by which the influ-
enza A virus penetrates the brain and
causes encephalopathy and encephalitis
has not yet been completely clarified. The
influenza A virus is replicated in the na-
sopharyngeal epithelium. The virus takes
invasive action to destroy the upper re-
spiratory tract epithelium. Olfactory mu-
cosa and its nerve endings are affected
with the inflammation. The influenza A
virus probably reaches the brain via the
olfactory nervous system18. The virus in-
teraction with glial cells results in the re-
lease of cytokines, especially TNF-.
TNF- causes brain cell lesions by the in-
hibition of intracellular mitochondrial
respiration18,19.
Penetration of the influenza A virus
into the brain by this route appears quite
probable, because it obviously does not
occur by the hematogenous route18–20. It
is of utmost importance to distinguish
whether these are manifestations of dif-
ferent diseases or pathophysiological se-
quels of the same disease entity.
Conclusion
In the patients presented, the course
of disease, clinical picture analysis, labo-
ratory findings and radiological study re-
sults pointed to encephalitis or encepha-
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lopathy caused by influenza A virus. The
exact pathogenetic mechanism of the as-
sociation between influenza virus and ce-
rebral manifestations remains an open
question, however, it should be admitted
that a seemingly plain influenza could
cause severe, permanent and even life-
threatening sequels. Therefore, caution is
warranted on approaching a patient with
influenza A and B. Timely prevention of
this seemingly simple but actually severe
infection is of utmost importance. Results
of the study pointed to the need of addi-
tional investigation aimed at a more dis-
tinct differentiation of biologically recog-
nizable and objective features of the di-
sease.
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ENCEFALITIS ILI ENCEFALOPATIJA TIJEKOM EPIDEMIJE
INFLUENCE-A
S A @ E T A K
Tijekom epidemije influence A (H1N1) u Osje~ko-baranjskoj `upaniji od 2000. do
2001. godine lije~eno je 6 bolesnica s encefalitisom. Najmla|a bolesnica imala je 17, a
najstarija 60 godina. Srednja `ivotna dob je 36.5 godina. Tri (50%) su bolesnice dobile
encefalitis 4-tog i 5-tog dana od pojave simptoma influence, a dvije (33.3%) tijekom prvih
24–48 sati od po~etka bolesti. Bolest se o~itovala glavoboljom, visokom temperaturom,
op}om slabo{}u i poreme}ajem svijesti do kome. Tri (50%) su bolesnice imale epi napad
tipa grand mal. U svih je bolesnica (100%) na|en patolo{ki EEG, u tri (50%) je na CT-u
na|en ja~i edem mozga. U dvije (33.3%) bolesnice u kojih se encefalitis javio prvih dana
influence na|ene su povi{ene vrijednosti jetrenih enzima i leukopenija u perifernoj
krvi. Jedna (16.6%) je bolesnica umrla, a u dvije (33.3%) ostale su trajne sekvele.
